Arterra Bioscience S.p.A. (BIT:ARBS)
2.260
+0.020 (0.88%)
Jun 6, 2025, 4:53 PM CET
Arterra Bioscience Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Cash & Equivalents | 3.34 | 3.69 | 4.39 | 4.81 | 4.54 | Upgrade
|
Trading Asset Securities | - | - | 1.6 | - | - | Upgrade
|
Cash & Short-Term Investments | 3.34 | 3.69 | 5.99 | 4.81 | 4.54 | Upgrade
|
Cash Growth | -9.29% | -38.48% | 24.46% | 6.13% | -2.85% | Upgrade
|
Accounts Receivable | 1.63 | 1.06 | 0.77 | 1.47 | 1.06 | Upgrade
|
Other Receivables | 1.98 | 1.78 | 1.88 | 1.71 | 1.63 | Upgrade
|
Receivables | 3.61 | 2.84 | 2.65 | 3.19 | 2.69 | Upgrade
|
Inventory | 1.33 | 1.36 | 1.16 | 0.49 | 0.57 | Upgrade
|
Other Current Assets | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Total Current Assets | 8.29 | 7.89 | 9.81 | 8.49 | 7.8 | Upgrade
|
Property, Plant & Equipment | 1.51 | 1.23 | 1.54 | 1.66 | 1.4 | Upgrade
|
Long-Term Investments | 3.45 | 3.35 | 0.98 | 0.95 | 0.45 | Upgrade
|
Other Intangible Assets | 0.03 | 0.04 | 0.05 | 0.13 | 0.1 | Upgrade
|
Long-Term Deferred Charges | 0 | - | 0.15 | 0.31 | 0.46 | Upgrade
|
Other Long-Term Assets | 0.11 | 0.04 | 0.04 | 0.04 | 0.11 | Upgrade
|
Total Assets | 13.4 | 12.55 | 12.57 | 11.58 | 10.32 | Upgrade
|
Accounts Payable | 0.28 | 0.25 | 0.19 | 0.25 | 0.19 | Upgrade
|
Accrued Expenses | 0.31 | 0.43 | 0.32 | 0.69 | 0.58 | Upgrade
|
Current Portion of Long-Term Debt | 0.1 | 0.09 | 0.17 | 0.22 | 0.22 | Upgrade
|
Current Income Taxes Payable | - | - | 0.23 | 0.02 | - | Upgrade
|
Other Current Liabilities | 0.14 | 0.08 | 0.24 | 0.05 | 0.05 | Upgrade
|
Total Current Liabilities | 0.82 | 0.84 | 1.16 | 1.23 | 1.03 | Upgrade
|
Long-Term Debt | 0.26 | 0.3 | 0.32 | 0.39 | 0.59 | Upgrade
|
Long-Term Deferred Tax Liabilities | 0.38 | 0.22 | 0.24 | 0.2 | 0.15 | Upgrade
|
Other Long-Term Liabilities | 0.52 | 0.44 | 0.39 | 0.29 | 0.37 | Upgrade
|
Total Liabilities | 1.98 | 1.8 | 2.1 | 2.11 | 2.14 | Upgrade
|
Common Stock | 0.33 | 0.33 | 0.33 | 0.33 | 0.33 | Upgrade
|
Additional Paid-In Capital | 4.17 | 4.17 | 4.17 | 4.17 | 3.99 | Upgrade
|
Retained Earnings | 7.25 | 6.58 | 6.17 | 5.08 | 3.97 | Upgrade
|
Treasury Stock | -0.33 | -0.33 | -0.2 | -0.11 | -0.11 | Upgrade
|
Shareholders' Equity | 11.42 | 10.75 | 10.47 | 9.47 | 8.18 | Upgrade
|
Total Liabilities & Equity | 13.4 | 12.55 | 12.57 | 11.58 | 10.32 | Upgrade
|
Total Debt | 0.36 | 0.39 | 0.49 | 0.61 | 0.81 | Upgrade
|
Net Cash (Debt) | 2.99 | 3.3 | 5.5 | 4.2 | 3.73 | Upgrade
|
Net Cash Growth | -9.48% | -40.03% | 31.02% | 12.69% | 1.62% | Upgrade
|
Net Cash Per Share | 0.45 | 0.50 | - | - | - | Upgrade
|
Filing Date Shares Outstanding | 6.66 | 6.66 | - | - | - | Upgrade
|
Total Common Shares Outstanding | 6.66 | 6.66 | - | - | - | Upgrade
|
Working Capital | 7.47 | 7.04 | 8.65 | 7.26 | 6.77 | Upgrade
|
Book Value Per Share | 1.72 | 1.61 | - | - | - | Upgrade
|
Tangible Book Value | 11.39 | 10.71 | 10.42 | 9.34 | 8.08 | Upgrade
|
Tangible Book Value Per Share | 1.71 | 1.61 | - | - | - | Upgrade
|
Land | 1.09 | 0.72 | 0.72 | 0.61 | 0.61 | Upgrade
|
Machinery | 2.57 | 2.43 | 2.41 | 2.61 | 2.06 | Upgrade
|
Construction In Progress | 0.01 | - | - | 0.01 | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.